MET and kidney cancer: Bulk RNA-seq datasets from 16 BHD-associated kidney cancers and 5 normal kidneys further showed that the expression levels of MET (p < 0.001) and vascular endothelial growth factor B (VEGFB) (p < 0.001) in BHD-associated kidney cancers were statistically higher than those in normal kidneys (Figures 5D and 5E and S4E and S4F).